Newsroom

10-10-2018

ACCORD HEALTHCARE - THE MOST RECOGNISED COMPANY AT THE GLOBAL GENERICS & BIOSIMILAR AWARDS 2018

We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year. 

Read More
27-07-2018

Accord Healthcare’s (Intas) Pelgraz® (pegfilgrastim) Given Green Light by CHMP

Pelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe  

Read More
12-06-2018

Continued growth in Europe

Over the past two weeks, we have continued to further our expansion in Europe with the opening of a new office in Basel, Switzerland and further expansion of operations in Austria.

Read More
30-04-2018

Accord Healthcare were honoured to be awarded the fastest growing Indian origin company in Britain awarded by Grant Thornton

The 'India Meets Britain Tracker 2018', released annually by Grant Thornton in collaboration with the Confederation of Indian Industry awards the fastest UK based companies of Indian origin.

Read More
13-04-2018

Paweł Mazur, East Area Director of Accord, featured in the Pharma Boardroom and the HCLS Review report on Poland

As East Area Director for the vast CEE market, Paweł Mazur explains how Accord Healthcare Poland

Read More
27-03-2018

Fawdon continues to grow and forge closer relationships with the local community

Our Fawdon factory in Newcastle recently welcomed Cllr Ged Bell, from Newcastle City Council and Keith Daniels, Site Head was able to bring him up to date with the latest news from the site.

Read More
19-03-2018

Growth in the Time of Brexit

Growth in the Time of Brexit: Pharm Exec speaks with our executive VP, Europe & EMENA, James Burt, about the company’s vision for the UK and Europe post-Brexit, the challenges of retaining the company’s culture amid major growth, and the current landscape for generic medicines.

Read More